Topiramate in Lennox-Gastaut syndrome : Open-label treatment of patients completing a randomized controlled trial
- Author
- GLAUSER, T. A1 ; LEVISOHN, P. M2 ; RITTER, F3 ; SACHDEO, R. C4
Topiramate YL Study Group
[1] Children's Hospital Medical Center, Cincinnati, Ohio, United States
[2] Division of Child Neurology Children's Epilepsy Program, The Children's Hospital, Denver, Colorado, United States
[3] Minnesota Epilepsy Group, P.A., St. Paul, Minnesota, United States
[4] Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States - Issue title
- Topiramate in epilepsy: a compendium of basic science and clinical research
- Author (monograph)
- WHITE, H. Steve (Editor)1 ; PRIVITERA, Michael D (Editor)2
[1] Department of Pharmacology and Toxicology, University of Utah College of Pharmacy, Salt Lake City, Utah, United States
[2] University of Neurology, University of Cincinnati, Cincinnati, Ohio, United States - Source
Epilepsia (Copenhagen). 2000, Vol 41, pp S86-S90 ; SUP1 ; ref : 26 ref
- Publisher
- Blackwell, Malden, MA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticonvulsivant Chimiothérapie Epilepsie Lennox Etude double insu Homme Long terme Pronostic Randomisation Topiramate Traitement adjuvant Encéphale pathologie Système nerveux central pathologie Système nerveux pathologie
- Keyword (en)
- Anticonvulsant Chemotherapy Lennox syndrome Double blind study Human Long term Prognosis Randomization Topiramate Adjuvant treatment Cerebral disorder Central nervous system disease Nervous system diseases
- Keyword (es)
- Anticonvulsivante Quimioterapia Epilepsia Lennox Estudio doble ciego Hombre Largo plazo Pronóstico Aleatorización Topiramato Tratamiento adyuvante Encéfalo patología Sistema nervosio central patología Sistema nervioso patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B06 Anticonvulsants. Antiepileptics. Antiparkinson agents
- Discipline
- Pharmacological treatments Psychopathology. Psychiatry. Clinical psychology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 1352875
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1111/j.1528-1157.2000.tb02179.x 
https://dx.doi.org/10.1111/j.1528-1157.2000.tb02179.x
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.1528-1157.2000.tb02179.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:113:\"Topiramate in Lennox-Gastaut syndrome : Open-label treatment of patients completing a randomized controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:22:\"Epilepsia (Copenhagen)\";s:9:\"\u0000*\u0000stitle\";s:16:\"Epilepsia (Cph.)\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"41\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:3:\"S86\";s:8:\"\u0000*\u0000epage\";s:3:\"S90\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0013-9580\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"GLAUSER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"T. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:14:\"LEVISOHN, P. M\";i:1;s:9:\"RITTER, F\";i:2;s:13:\"SACHDEO, R. C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"EPILAK\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:4:\"SUP1\";s:9:\"\u0000*\u0000btitle\";s:75:\"Topiramate in epilepsy: a compendium of basic science and clinical research\";s:8:\"\u0000*\u0000title\";s:113:\"Topiramate in Lennox-Gastaut syndrome : Open-label treatment of patients completing a randomized controlled trial\";s:8:\"\u0000*\u0000place\";s:10:\"Malden, MA\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.1528-1157.2000.tb02179.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:113:\"Topiramate in Lennox-Gastaut syndrome : Open-label treatment of patients completing a randomized controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:22:\"Epilepsia (Copenhagen)\";s:9:\"\u0000*\u0000stitle\";s:16:\"Epilepsia (Cph.)\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"41\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:3:\"S86\";s:8:\"\u0000*\u0000epage\";s:3:\"S90\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0013-9580\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"GLAUSER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"T. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:14:\"LEVISOHN, P. M\";i:1;s:9:\"RITTER, F\";i:2;s:13:\"SACHDEO, R. C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"EPILAK\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:4:\"SUP1\";s:9:\"\u0000*\u0000btitle\";s:75:\"Topiramate in epilepsy: a compendium of basic science and clinical research\";s:8:\"\u0000*\u0000title\";s:113:\"Topiramate in Lennox-Gastaut syndrome : Open-label treatment of patients completing a randomized controlled trial\";s:8:\"\u0000*\u0000place\";s:10:\"Malden, MA\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.1528-1157.2000.tb02179.x\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.1528-1157.2000.tb02179.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:113:\"Topiramate in Lennox-Gastaut syndrome : Open-label treatment of patients completing a randomized controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:22:\"Epilepsia (Copenhagen)\";s:9:\"\u0000*\u0000stitle\";s:16:\"Epilepsia (Cph.)\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"41\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:3:\"S86\";s:8:\"\u0000*\u0000epage\";s:3:\"S90\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0013-9580\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"GLAUSER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"T. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:14:\"LEVISOHN, P. M\";i:1;s:9:\"RITTER, F\";i:2;s:13:\"SACHDEO, R. C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"EPILAK\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:4:\"SUP1\";s:9:\"\u0000*\u0000btitle\";s:75:\"Topiramate in epilepsy: a compendium of basic science and clinical research\";s:8:\"\u0000*\u0000title\";s:113:\"Topiramate in Lennox-Gastaut syndrome : Open-label treatment of patients completing a randomized controlled trial\";s:8:\"\u0000*\u0000place\";s:10:\"Malden, MA\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.1528-1157.2000.tb02179.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:113:\"Topiramate in Lennox-Gastaut syndrome : Open-label treatment of patients completing a randomized controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:22:\"Epilepsia (Copenhagen)\";s:9:\"\u0000*\u0000stitle\";s:16:\"Epilepsia (Cph.)\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"41\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:3:\"S86\";s:8:\"\u0000*\u0000epage\";s:3:\"S90\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0013-9580\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"GLAUSER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"T. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:14:\"LEVISOHN, P. M\";i:1;s:9:\"RITTER, F\";i:2;s:13:\"SACHDEO, R. C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"EPILAK\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:4:\"SUP1\";s:9:\"\u0000*\u0000btitle\";s:75:\"Topiramate in epilepsy: a compendium of basic science and clinical research\";s:8:\"\u0000*\u0000title\";s:113:\"Topiramate in Lennox-Gastaut syndrome : Open-label treatment of patients completing a randomized controlled trial\";s:8:\"\u0000*\u0000place\";s:10:\"Malden, MA\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.1528-1157.2000.tb02179.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:113:\"Topiramate in Lennox-Gastaut syndrome : Open-label treatment of patients completing a randomized controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:22:\"Epilepsia (Copenhagen)\";s:9:\"\u0000*\u0000stitle\";s:16:\"Epilepsia (Cph.)\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"41\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:3:\"S86\";s:8:\"\u0000*\u0000epage\";s:3:\"S90\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0013-9580\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"GLAUSER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"T. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:14:\"LEVISOHN, P. M\";i:1;s:9:\"RITTER, F\";i:2;s:13:\"SACHDEO, R. C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"EPILAK\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:4:\"SUP1\";s:9:\"\u0000*\u0000btitle\";s:75:\"Topiramate in epilepsy: a compendium of basic science and clinical research\";s:8:\"\u0000*\u0000title\";s:113:\"Topiramate in Lennox-Gastaut syndrome : Open-label treatment of patients completing a randomized controlled trial\";s:8:\"\u0000*\u0000place\";s:10:\"Malden, MA\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
